Survival following cytoreductive nephrectomy: a comparison of existing prognostic models.
Mary E WestermanDaniel D ShapiroNizar M TannirMatthew T CampbellSurena F MatinJose Antonio KaramChristopher G WoodPublished in: BJU international (2020)
Currently used prognostic models have limited discriminatory capacity when applied to a modern cohort of patients undergoing CN. They are inadequate for risk stratification and randomisation in prospective clinical trials of untreated patients with mRCC. Caution should be used when using these models for clinical decision making.